| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Pancreatic Ductal | 15 | 2024 | 1819 | 1.560 |
Why?
|
| Pancreatic Neoplasms | 17 | 2024 | 5235 | 1.410 |
Why?
|
| Cell Cycle | 36 | 2014 | 2152 | 1.380 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 8 | 2024 | 1408 | 1.280 |
Why?
|
| cdc25 Phosphatases | 14 | 2005 | 101 | 1.270 |
Why?
|
| Oxidative Phosphorylation | 7 | 2022 | 267 | 1.260 |
Why?
|
| Cyclins | 26 | 1999 | 470 | 1.030 |
Why?
|
| Mitochondria | 8 | 2023 | 1318 | 1.030 |
Why?
|
| CDC2 Protein Kinase | 30 | 1995 | 188 | 1.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2021 | 844 | 0.920 |
Why?
|
| Protein Kinases | 24 | 2004 | 917 | 0.870 |
Why?
|
| Cyclin-Dependent Kinases | 17 | 2005 | 323 | 0.860 |
Why?
|
| Ecosystem | 2 | 2024 | 110 | 0.790 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2021 | 6 | 0.780 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 161 | 0.720 |
Why?
|
| Pinocytosis | 1 | 2019 | 28 | 0.660 |
Why?
|
| Syndecan-1 | 1 | 2019 | 54 | 0.660 |
Why?
|
| Cell Cycle Proteins | 25 | 2017 | 2125 | 0.660 |
Why?
|
| Ubiquitins | 7 | 2004 | 100 | 0.640 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 352 | 0.630 |
Why?
|
| Gene Library | 1 | 2019 | 357 | 0.610 |
Why?
|
| Neoplasms | 18 | 2020 | 15852 | 0.600 |
Why?
|
| Schizosaccharomyces | 11 | 1995 | 118 | 0.600 |
Why?
|
| S Phase | 7 | 2009 | 290 | 0.590 |
Why?
|
| Drug Discovery | 3 | 2021 | 326 | 0.570 |
Why?
|
| Drug Resistance, Neoplasm | 9 | 2021 | 5427 | 0.560 |
Why?
|
| Carrier Proteins | 8 | 2015 | 2123 | 0.550 |
Why?
|
| Glioblastoma | 4 | 2022 | 1777 | 0.550 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 3 | 2005 | 40 | 0.530 |
Why?
|
| Phosphoproteins | 14 | 2017 | 1229 | 0.520 |
Why?
|
| CDC2-CDC28 Kinases | 7 | 1994 | 132 | 0.500 |
Why?
|
| Antineoplastic Agents | 14 | 2021 | 14679 | 0.500 |
Why?
|
| Drug Resistance, Multiple | 1 | 2016 | 221 | 0.490 |
Why?
|
| Animals | 83 | 2023 | 62801 | 0.490 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2021 | 3929 | 0.480 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2017 | 685 | 0.480 |
Why?
|
| HeLa Cells | 24 | 2007 | 1719 | 0.480 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 461 | 0.430 |
Why?
|
| Transcription Factors | 11 | 2020 | 5493 | 0.430 |
Why?
|
| Mutation | 16 | 2024 | 15859 | 0.430 |
Why?
|
| Mice | 46 | 2023 | 36026 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 388 | 0.420 |
Why?
|
| Enzyme Inhibitors | 7 | 2021 | 1984 | 0.420 |
Why?
|
| Ligases | 5 | 2004 | 85 | 0.410 |
Why?
|
| DNA Damage | 7 | 2021 | 1980 | 0.410 |
Why?
|
| DNA-Binding Proteins | 12 | 2020 | 5042 | 0.400 |
Why?
|
| Humans | 127 | 2024 | 270825 | 0.400 |
Why?
|
| High Mobility Group Proteins | 1 | 2011 | 65 | 0.390 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2011 | 42 | 0.390 |
Why?
|
| Amino Acid Sequence | 23 | 2007 | 4641 | 0.380 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2021 | 65 | 0.370 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2021 | 3657 | 0.370 |
Why?
|
| Molecular Sequence Data | 24 | 2016 | 6784 | 0.360 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2019 | 1467 | 0.360 |
Why?
|
| Fungal Proteins | 7 | 1995 | 271 | 0.360 |
Why?
|
| Schizosaccharomyces pombe Proteins | 5 | 1995 | 84 | 0.360 |
Why?
|
| RNA-Binding Proteins | 3 | 2022 | 1019 | 0.350 |
Why?
|
| Mitosis | 12 | 2000 | 690 | 0.350 |
Why?
|
| G1 Phase | 9 | 2009 | 306 | 0.340 |
Why?
|
| Amyloid Precursor Protein Secretases | 5 | 2010 | 101 | 0.330 |
Why?
|
| Cell Division | 10 | 2015 | 2716 | 0.330 |
Why?
|
| Endopeptidases | 2 | 2001 | 233 | 0.310 |
Why?
|
| Ribosomes | 2 | 2006 | 170 | 0.310 |
Why?
|
| Phosphorylation | 26 | 2017 | 4990 | 0.300 |
Why?
|
| Fatty Acids | 2 | 2021 | 448 | 0.300 |
Why?
|
| Glycolysis | 5 | 2019 | 534 | 0.300 |
Why?
|
| Neoplastic Stem Cells | 5 | 2021 | 1469 | 0.290 |
Why?
|
| Cell Line, Tumor | 22 | 2021 | 14875 | 0.290 |
Why?
|
| Pancreas | 2 | 2021 | 744 | 0.290 |
Why?
|
| Protein Binding | 11 | 2020 | 3536 | 0.270 |
Why?
|
| RNA, Double-Stranded | 1 | 2006 | 96 | 0.270 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2006 | 95 | 0.260 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2021 | 4956 | 0.260 |
Why?
|
| Enzyme Activation | 17 | 2010 | 1834 | 0.250 |
Why?
|
| Neoplasms, Experimental | 3 | 2021 | 791 | 0.250 |
Why?
|
| SMARCB1 Protein | 3 | 2023 | 109 | 0.250 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2023 | 2413 | 0.240 |
Why?
|
| Viral Proteins | 5 | 2004 | 494 | 0.240 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 2 | 2002 | 46 | 0.240 |
Why?
|
| Cell Proliferation | 9 | 2021 | 7302 | 0.240 |
Why?
|
| Plasmids | 9 | 2016 | 952 | 0.240 |
Why?
|
| NF-kappa B | 1 | 2011 | 1584 | 0.240 |
Why?
|
| Ubiquitin | 7 | 2007 | 337 | 0.240 |
Why?
|
| Phosphoprotein Phosphatases | 6 | 1997 | 223 | 0.230 |
Why?
|
| Cell Nucleolus | 1 | 2004 | 102 | 0.230 |
Why?
|
| Oncogene Proteins | 4 | 1997 | 371 | 0.230 |
Why?
|
| Genes, Fungal | 6 | 1994 | 97 | 0.230 |
Why?
|
| RNA Precursors | 1 | 2004 | 125 | 0.230 |
Why?
|
| Kidney Neoplasms | 3 | 2023 | 3143 | 0.220 |
Why?
|
| Pyridines | 3 | 2021 | 1312 | 0.220 |
Why?
|
| Sickle Cell Trait | 1 | 2023 | 24 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2020 | 9083 | 0.220 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2004 | 472 | 0.220 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2005 | 335 | 0.220 |
Why?
|
| Models, Biological | 7 | 2016 | 3226 | 0.210 |
Why?
|
| Cyclic S-Oxides | 4 | 2010 | 12 | 0.210 |
Why?
|
| Amino Acid Motifs | 4 | 2004 | 414 | 0.210 |
Why?
|
| Carcinogenesis | 2 | 2021 | 1031 | 0.210 |
Why?
|
| Isoenzymes | 2 | 2017 | 663 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 4 | 2021 | 1132 | 0.210 |
Why?
|
| Thiadiazoles | 4 | 2010 | 61 | 0.200 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2022 | 72 | 0.200 |
Why?
|
| Oncogenes | 3 | 2021 | 700 | 0.200 |
Why?
|
| Transfection | 11 | 2016 | 3169 | 0.200 |
Why?
|
| Nuclear Proteins | 8 | 2015 | 3460 | 0.200 |
Why?
|
| Acinar Cells | 1 | 2021 | 55 | 0.190 |
Why?
|
| Neoplasm Proteins | 6 | 2021 | 3349 | 0.190 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2020 | 704 | 0.190 |
Why?
|
| Genes, ras | 3 | 2021 | 680 | 0.190 |
Why?
|
| Oxadiazoles | 1 | 2021 | 60 | 0.190 |
Why?
|
| Protein Tyrosine Phosphatases | 4 | 1997 | 188 | 0.190 |
Why?
|
| DNA Replication | 7 | 2014 | 771 | 0.190 |
Why?
|
| Receptors, Notch | 3 | 2010 | 377 | 0.190 |
Why?
|
| Transcriptome | 5 | 2024 | 1933 | 0.190 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2004 | 97 | 0.190 |
Why?
|
| Signal Transduction | 14 | 2019 | 12206 | 0.180 |
Why?
|
| Resorcinols | 1 | 2020 | 25 | 0.180 |
Why?
|
| Structure-Activity Relationship | 8 | 2021 | 1011 | 0.180 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 26 | 0.180 |
Why?
|
| Rhabdoid Tumor | 2 | 2019 | 111 | 0.180 |
Why?
|
| Repressor Proteins | 4 | 2021 | 1726 | 0.180 |
Why?
|
| RNA Splicing | 2 | 2017 | 358 | 0.180 |
Why?
|
| Isoxazoles | 1 | 2020 | 79 | 0.180 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2019 | 195 | 0.180 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2020 | 193 | 0.170 |
Why?
|
| Glutaminase | 1 | 2020 | 71 | 0.170 |
Why?
|
| Benzothiazoles | 1 | 2020 | 101 | 0.170 |
Why?
|
| Karyopherins | 1 | 2021 | 134 | 0.170 |
Why?
|
| Integrins | 1 | 2021 | 277 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2021 | 1372 | 0.170 |
Why?
|
| Kinetics | 15 | 2004 | 2246 | 0.170 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 221 | 0.170 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2019 | 32 | 0.170 |
Why?
|
| Phosphogluconate Dehydrogenase | 1 | 2019 | 9 | 0.170 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 4774 | 0.170 |
Why?
|
| Fibroblasts | 6 | 2004 | 1669 | 0.160 |
Why?
|
| Anilides | 1 | 2021 | 296 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2004 | 687 | 0.160 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2019 | 32 | 0.160 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2021 | 435 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 12 | 2021 | 5834 | 0.160 |
Why?
|
| Pancreatitis | 1 | 2021 | 292 | 0.160 |
Why?
|
| Carbon-Nitrogen Lyases | 1 | 1998 | 3 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2016 | 1293 | 0.160 |
Why?
|
| Metabolome | 1 | 2021 | 355 | 0.160 |
Why?
|
| Piperidines | 2 | 2021 | 1090 | 0.160 |
Why?
|
| Tumor Microenvironment | 5 | 2022 | 2989 | 0.160 |
Why?
|
| Proteostasis | 1 | 2019 | 49 | 0.160 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2019 | 88 | 0.160 |
Why?
|
| Biochemistry | 1 | 1998 | 23 | 0.150 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 2214 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 886 | 0.150 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 163 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2004 | 1091 | 0.150 |
Why?
|
| Receptor, Notch1 | 2 | 2009 | 220 | 0.150 |
Why?
|
| Health Planning | 1 | 2017 | 31 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 5 | 1999 | 532 | 0.150 |
Why?
|
| Health Priorities | 1 | 2017 | 45 | 0.150 |
Why?
|
| Nuclear Factor 45 Protein | 1 | 2017 | 12 | 0.150 |
Why?
|
| DNA Helicases | 2 | 2015 | 449 | 0.140 |
Why?
|
| Apoptosis | 6 | 2021 | 7853 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 322 | 0.140 |
Why?
|
| Malate Dehydrogenase | 1 | 2017 | 20 | 0.140 |
Why?
|
| Molecular Biology | 1 | 1998 | 183 | 0.140 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 218 | 0.140 |
Why?
|
| Glucose | 2 | 2015 | 1249 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2399 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2002 | 1884 | 0.140 |
Why?
|
| Oncogene Proteins, Viral | 5 | 1992 | 147 | 0.140 |
Why?
|
| Gene Editing | 1 | 2019 | 231 | 0.140 |
Why?
|
| F-Box Proteins | 2 | 2007 | 99 | 0.140 |
Why?
|
| Macromolecular Substances | 5 | 2004 | 343 | 0.140 |
Why?
|
| Adenocarcinoma | 6 | 2019 | 7936 | 0.140 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 1988 | 38 | 0.140 |
Why?
|
| DNA, Complementary | 5 | 2015 | 956 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 641 | 0.140 |
Why?
|
| Immunoblotting | 7 | 2001 | 916 | 0.140 |
Why?
|
| RNA | 1 | 2021 | 1067 | 0.140 |
Why?
|
| Disease Progression | 2 | 2019 | 6892 | 0.130 |
Why?
|
| Triazoles | 1 | 2020 | 630 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2016 | 1666 | 0.130 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 45 | 0.130 |
Why?
|
| Recombinant Proteins | 8 | 2020 | 3073 | 0.130 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 263 | 0.130 |
Why?
|
| Indoles | 2 | 2021 | 1035 | 0.130 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 319 | 0.130 |
Why?
|
| Lentivirus | 1 | 2016 | 167 | 0.130 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 958 | 0.130 |
Why?
|
| Binding Sites | 7 | 2004 | 2306 | 0.130 |
Why?
|
| Drug Costs | 1 | 2017 | 141 | 0.130 |
Why?
|
| Recombinational DNA Repair | 1 | 2016 | 78 | 0.130 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 1436 | 0.130 |
Why?
|
| Genes, Mitochondrial | 1 | 2015 | 26 | 0.130 |
Why?
|
| Calmodulin | 5 | 1988 | 264 | 0.130 |
Why?
|
| Pyrimidines | 4 | 2021 | 3666 | 0.130 |
Why?
|
| Histone Deacetylases | 4 | 2007 | 366 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 318 | 0.130 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 2 | 1993 | 99 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2021 | 2471 | 0.130 |
Why?
|
| Cell Line | 14 | 2001 | 5435 | 0.130 |
Why?
|
| Citric Acid Cycle | 1 | 2015 | 94 | 0.130 |
Why?
|
| Protein Kinase C | 1 | 2017 | 419 | 0.130 |
Why?
|
| DNA End-Joining Repair | 1 | 2016 | 92 | 0.130 |
Why?
|
| Retinoblastoma Protein | 4 | 2009 | 342 | 0.130 |
Why?
|
| Adenosine Triphosphate | 4 | 2015 | 594 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1010 | 0.130 |
Why?
|
| Base Sequence | 10 | 2016 | 5494 | 0.120 |
Why?
|
| Protein Subunits | 1 | 2016 | 282 | 0.120 |
Why?
|
| Mice, SCID | 4 | 2021 | 1855 | 0.120 |
Why?
|
| Azabicyclo Compounds | 1 | 2015 | 40 | 0.120 |
Why?
|
| Cloning, Molecular | 6 | 1995 | 1460 | 0.120 |
Why?
|
| Autophagy | 2 | 2019 | 920 | 0.120 |
Why?
|
| Endonucleases | 1 | 2016 | 183 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 1004 | 0.120 |
Why?
|
| Mesoderm | 1 | 2017 | 397 | 0.120 |
Why?
|
| Immune Tolerance | 1 | 2017 | 430 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2016 | 265 | 0.120 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 7465 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2014 | 2617 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2021 | 1157 | 0.120 |
Why?
|
| DNA Repair Enzymes | 1 | 2016 | 234 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 513 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 2 | 7 | 1994 | 253 | 0.120 |
Why?
|
| Molecular Structure | 3 | 2021 | 536 | 0.120 |
Why?
|
| Benzimidazoles | 2 | 2015 | 442 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 388 | 0.110 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2021 | 1735 | 0.110 |
Why?
|
| Hydroxamic Acids | 2 | 2015 | 459 | 0.110 |
Why?
|
| Glioma | 2 | 2022 | 1969 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2015 | 313 | 0.110 |
Why?
|
| Microinjections | 4 | 1995 | 107 | 0.110 |
Why?
|
| Female | 29 | 2022 | 148456 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1993 | 1842 | 0.110 |
Why?
|
| Pyrroles | 1 | 2017 | 592 | 0.110 |
Why?
|
| Oncogene Protein v-akt | 2 | 2011 | 104 | 0.110 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2019 | 746 | 0.110 |
Why?
|
| DNA | 5 | 2016 | 3072 | 0.110 |
Why?
|
| Drug Design | 1 | 2015 | 378 | 0.110 |
Why?
|
| Substrate Specificity | 9 | 2016 | 582 | 0.110 |
Why?
|
| Precipitin Tests | 4 | 2004 | 362 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2016 | 493 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 294 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 381 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 1656 | 0.100 |
Why?
|
| Cytoplasm | 3 | 2004 | 718 | 0.100 |
Why?
|
| Precision Medicine | 3 | 2017 | 1201 | 0.100 |
Why?
|
| Genes, Regulator | 3 | 1993 | 83 | 0.100 |
Why?
|
| Multienzyme Complexes | 3 | 1999 | 231 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2016 | 879 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 3 | 1999 | 266 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 10350 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 5 | 1995 | 1152 | 0.100 |
Why?
|
| Molecular Weight | 6 | 2001 | 728 | 0.100 |
Why?
|
| ErbB Receptors | 3 | 2021 | 2379 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2017 | 1482 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 1065 | 0.100 |
Why?
|
| Peptide Fragments | 4 | 2009 | 1327 | 0.100 |
Why?
|
| Mice, Nude | 5 | 2021 | 4360 | 0.100 |
Why?
|
| Serine | 2 | 2004 | 396 | 0.100 |
Why?
|
| Proteins | 4 | 1994 | 2047 | 0.090 |
Why?
|
| Genes, Viral | 2 | 1991 | 257 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 5325 | 0.090 |
Why?
|
| Pathology, Molecular | 1 | 2011 | 124 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 1725 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 1502 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 1571 | 0.090 |
Why?
|
| Adenoviridae | 4 | 2003 | 1510 | 0.090 |
Why?
|
| Cells, Cultured | 9 | 2021 | 5780 | 0.090 |
Why?
|
| RNA Interference | 4 | 2021 | 1398 | 0.090 |
Why?
|
| Colorectal Neoplasms | 3 | 2021 | 3661 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 802 | 0.090 |
Why?
|
| DNA Repair | 2 | 2017 | 1886 | 0.090 |
Why?
|
| Down-Regulation | 4 | 2020 | 2109 | 0.090 |
Why?
|
| Cell Nucleus | 6 | 2002 | 1742 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 1093 | 0.090 |
Why?
|
| Invertebrate Hormones | 1 | 1989 | 5 | 0.080 |
Why?
|
| Biocatalysis | 2 | 2021 | 64 | 0.080 |
Why?
|
| Bivalvia | 1 | 1989 | 16 | 0.080 |
Why?
|
| Genes | 2 | 1987 | 611 | 0.080 |
Why?
|
| Nocodazole | 4 | 2000 | 28 | 0.080 |
Why?
|
| Administration, Oral | 3 | 2021 | 1618 | 0.080 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2001 | 224 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2004 | 884 | 0.080 |
Why?
|
| Gene Expression Profiling | 5 | 2024 | 5163 | 0.080 |
Why?
|
| 3T3 Cells | 3 | 2004 | 387 | 0.080 |
Why?
|
| Growth Substances | 1 | 1989 | 329 | 0.080 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 911 | 0.080 |
Why?
|
| Biomarkers, Tumor | 5 | 2021 | 10698 | 0.080 |
Why?
|
| Protamine Kinase | 5 | 1992 | 19 | 0.080 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 4186 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2021 | 2908 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 214 | 0.070 |
Why?
|
| E2F Transcription Factors | 5 | 2014 | 138 | 0.070 |
Why?
|
| Adenoviridae Infections | 1 | 1988 | 114 | 0.070 |
Why?
|
| Peptides | 3 | 2004 | 1529 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2016 | 1669 | 0.070 |
Why?
|
| Male | 20 | 2021 | 128398 | 0.070 |
Why?
|
| Lidocaine | 2 | 1985 | 79 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2093 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 7 | 2009 | 298 | 0.070 |
Why?
|
| Flavoproteins | 1 | 2007 | 32 | 0.070 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2007 | 45 | 0.070 |
Why?
|
| Saccharomycetales | 1 | 1987 | 47 | 0.070 |
Why?
|
| G2 Phase | 3 | 2007 | 218 | 0.070 |
Why?
|
| Phenotype | 2 | 2016 | 6464 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2022 | 718 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 428 | 0.070 |
Why?
|
| Rats | 11 | 2020 | 6639 | 0.070 |
Why?
|
| Cell Line, Transformed | 3 | 1997 | 431 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 72 | 0.070 |
Why?
|
| Heterografts | 2 | 2021 | 745 | 0.070 |
Why?
|
| Procainamide | 2 | 1985 | 11 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 1014 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 4124 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 2321 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 1011 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2019 | 3533 | 0.060 |
Why?
|
| Sarcolemma | 1 | 1985 | 31 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1998 | 643 | 0.060 |
Why?
|
| Cyclin D1 | 4 | 1997 | 589 | 0.060 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 2 | 2002 | 28 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 327 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2021 | 1567 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 4 | 4 | 2009 | 212 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2015 | 627 | 0.060 |
Why?
|
| Trans-Activators | 3 | 2007 | 1655 | 0.060 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2004 | 50 | 0.060 |
Why?
|
| Adenovirus Early Proteins | 4 | 1992 | 12 | 0.060 |
Why?
|
| Half-Life | 2 | 2020 | 269 | 0.060 |
Why?
|
| DNA Copy Number Variations | 2 | 2023 | 1546 | 0.060 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2004 | 36 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2010 | 2474 | 0.060 |
Why?
|
| Mechlorethamine | 2 | 1994 | 55 | 0.060 |
Why?
|
| Histone Deacetylase 1 | 4 | 2007 | 63 | 0.060 |
Why?
|
| RNA, Ribosomal | 1 | 2004 | 94 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2004 | 831 | 0.060 |
Why?
|
| Ribonucleoproteins | 1 | 2004 | 114 | 0.060 |
Why?
|
| Tumor Burden | 2 | 2021 | 2034 | 0.060 |
Why?
|
| Models, Molecular | 4 | 2016 | 1757 | 0.060 |
Why?
|
| Blotting, Western | 6 | 2004 | 3648 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 3859 | 0.060 |
Why?
|
| Phospholipid Ethers | 1 | 2023 | 14 | 0.060 |
Why?
|
| Testis | 1 | 1988 | 753 | 0.060 |
Why?
|
| Adenovirus E4 Proteins | 1 | 2003 | 17 | 0.060 |
Why?
|
| Genes, myc | 2 | 2017 | 374 | 0.060 |
Why?
|
| Chromatin | 2 | 2021 | 1050 | 0.050 |
Why?
|
| Adenylyl Cyclases | 5 | 1986 | 103 | 0.050 |
Why?
|
| SUMO-1 Protein | 1 | 2002 | 22 | 0.050 |
Why?
|
| Cdc20 Proteins | 1 | 2002 | 27 | 0.050 |
Why?
|
| Radiation, Ionizing | 1 | 2003 | 191 | 0.050 |
Why?
|
| Tyrosine | 4 | 1993 | 510 | 0.050 |
Why?
|
| Protein Conformation | 3 | 1999 | 1280 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2018 | 1473 | 0.050 |
Why?
|
| Genomics | 3 | 2021 | 2818 | 0.050 |
Why?
|
| Gene Expression | 7 | 2002 | 3679 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2004 | 751 | 0.050 |
Why?
|
| Aviadenovirus | 1 | 2002 | 1 | 0.050 |
Why?
|
| Brain Neoplasms | 3 | 2018 | 4980 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 3 | 1994 | 4519 | 0.050 |
Why?
|
| Phospholipids | 1 | 2023 | 171 | 0.050 |
Why?
|
| Deoxycytidine | 2 | 2019 | 1377 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 658 | 0.050 |
Why?
|
| Biological Evolution | 2 | 1994 | 286 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2023 | 229 | 0.050 |
Why?
|
| Aneuploidy | 1 | 2023 | 377 | 0.050 |
Why?
|
| Myocardium | 2 | 1985 | 1250 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2021 | 73 | 0.050 |
Why?
|
| Interphase | 4 | 1994 | 156 | 0.050 |
Why?
|
| Polyvinyl Chloride | 1 | 1981 | 9 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2002 | 109 | 0.050 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2001 | 19 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 1994 | 204 | 0.050 |
Why?
|
| Polyvinyls | 1 | 1981 | 21 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2021 | 66 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 1037 | 0.050 |
Why?
|
| Receptor, ErbB-2 | 2 | 2010 | 2648 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 783 | 0.050 |
Why?
|
| Hydroxyurea | 2 | 2000 | 223 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2004 | 909 | 0.050 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2001 | 118 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2021 | 157 | 0.050 |
Why?
|
| Breast Neoplasms | 4 | 2015 | 16193 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 4373 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2021 | 217 | 0.050 |
Why?
|
| Microsomes | 1 | 2020 | 77 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 5103 | 0.050 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2020 | 19 | 0.050 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 4 | 1993 | 57 | 0.050 |
Why?
|
| Transcription Factor DP1 | 4 | 1993 | 59 | 0.050 |
Why?
|
| RNA Helicases | 1 | 2001 | 103 | 0.050 |
Why?
|
| Phosphotransferases | 2 | 1992 | 84 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 5 | 2007 | 3246 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2020 | 54 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 48 | 0.050 |
Why?
|
| Drug Stability | 1 | 2020 | 108 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2000 | 112 | 0.050 |
Why?
|
| Ribonucleotide Reductases | 1 | 2000 | 48 | 0.040 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2004 | 112 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 139 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 71 | 0.040 |
Why?
|
| Acrylamides | 1 | 2020 | 69 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2021 | 354 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2021 | 5835 | 0.040 |
Why?
|
| Intestine, Large | 1 | 1980 | 32 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 285 | 0.040 |
Why?
|
| Hypoxia | 1 | 2023 | 467 | 0.040 |
Why?
|
| Microsomes, Liver | 1 | 2020 | 119 | 0.040 |
Why?
|
| Metaplasia | 1 | 2021 | 386 | 0.040 |
Why?
|
| Phosphates | 2 | 1993 | 193 | 0.040 |
Why?
|
| Wnt-5a Protein | 1 | 2019 | 46 | 0.040 |
Why?
|
| Macrophages | 2 | 2022 | 1368 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 573 | 0.040 |
Why?
|
| Cetuximab | 1 | 2021 | 474 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2019 | 53 | 0.040 |
Why?
|
| Cell Survival | 3 | 2014 | 3081 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1993 | 615 | 0.040 |
Why?
|
| Morpholines | 1 | 2021 | 297 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 202 | 0.040 |
Why?
|
| Fumarate Hydratase | 1 | 2019 | 13 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2005 | 2466 | 0.040 |
Why?
|
| Respiration | 1 | 2021 | 465 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 664 | 0.040 |
Why?
|
| Societies, Scientific | 1 | 2019 | 69 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 504 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 1168 | 0.040 |
Why?
|
| Microtubules | 2 | 1992 | 330 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1991 | 423 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2020 | 206 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 163 | 0.040 |
Why?
|
| Oocytes | 2 | 1993 | 422 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 16598 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 350 | 0.040 |
Why?
|
| Leukemia | 1 | 2007 | 1720 | 0.040 |
Why?
|
| Species Specificity | 2 | 2004 | 809 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 114 | 0.040 |
Why?
|
| San Francisco | 1 | 1998 | 22 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5531 | 0.040 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 1998 | 67 | 0.040 |
Why?
|
| Intestinal Neoplasms | 1 | 1980 | 201 | 0.040 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 368 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 153 | 0.040 |
Why?
|
| Xenopus | 3 | 1993 | 237 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 960 | 0.040 |
Why?
|
| Nucleotides | 1 | 2018 | 174 | 0.040 |
Why?
|
| Computational Biology | 2 | 2016 | 1263 | 0.040 |
Why?
|
| Splicing Factor U2AF | 1 | 2017 | 44 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 738 | 0.040 |
Why?
|
| Proteasome Inhibitors | 1 | 2019 | 238 | 0.040 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2017 | 44 | 0.040 |
Why?
|
| Histones | 4 | 2007 | 1513 | 0.040 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2017 | 19 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 246 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2017 | 44 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 40 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2017 | 43 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2019 | 296 | 0.040 |
Why?
|
| Clonal Evolution | 1 | 2019 | 251 | 0.040 |
Why?
|
| Genes, cdc | 1 | 1997 | 84 | 0.040 |
Why?
|
| NADP | 1 | 2017 | 91 | 0.030 |
Why?
|
| Transaminases | 1 | 2017 | 82 | 0.030 |
Why?
|
| Laryngeal Neoplasms | 1 | 1980 | 532 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2017 | 146 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2005 | 603 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 116 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 2015 | 339 | 0.030 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 11775 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 505 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2018 | 312 | 0.030 |
Why?
|
| Cattle | 2 | 1988 | 846 | 0.030 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2017 | 102 | 0.030 |
Why?
|
| Prognosis | 5 | 2021 | 22452 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 1999 | 496 | 0.030 |
Why?
|
| Geminin | 1 | 2016 | 9 | 0.030 |
Why?
|
| Escherichia coli | 5 | 1990 | 1308 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2017 | 187 | 0.030 |
Why?
|
| Cyclic AMP | 3 | 1988 | 404 | 0.030 |
Why?
|
| Epithelial Cells | 2 | 2021 | 1887 | 0.030 |
Why?
|
| Genetic Engineering | 2 | 2016 | 299 | 0.030 |
Why?
|
| Genes, p53 | 3 | 2014 | 1133 | 0.030 |
Why?
|
| Adenine | 1 | 2019 | 667 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1997 | 269 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 2364 | 0.030 |
Why?
|
| Drug Approval | 1 | 2017 | 178 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 2 | 1995 | 93 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2016 | 102 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 2254 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 1998 | 580 | 0.030 |
Why?
|
| Thiamine | 1 | 1995 | 10 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2015 | 148 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1999 | 558 | 0.030 |
Why?
|
| Buthionine Sulfoximine | 1 | 2015 | 42 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 184 | 0.030 |
Why?
|
| Brain | 1 | 1988 | 4245 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1547 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 2 | 2007 | 36 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 246 | 0.030 |
Why?
|
| Proteolysis | 1 | 2017 | 380 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 512 | 0.030 |
Why?
|
| Mosaicism | 1 | 2017 | 287 | 0.030 |
Why?
|
| Keratinocytes | 2 | 1992 | 247 | 0.030 |
Why?
|
| Forecasting | 1 | 2017 | 707 | 0.030 |
Why?
|
| Epigenomics | 1 | 2016 | 268 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 203 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2014 | 54 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 164 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 272 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 2006 | 1062 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 395 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 2260 | 0.030 |
Why?
|
| Membrane Fluidity | 2 | 1985 | 22 | 0.030 |
Why?
|
| Sarcoma, Synovial | 1 | 2015 | 130 | 0.030 |
Why?
|
| Multigene Family | 1 | 1995 | 459 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 340 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 405 | 0.030 |
Why?
|
| Immunohistochemistry | 6 | 1999 | 7810 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 589 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 503 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 626 | 0.030 |
Why?
|
| Bevacizumab | 1 | 2017 | 959 | 0.030 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1993 | 21 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 1994 | 60 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2007 | 3086 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 328 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 1994 | 148 | 0.030 |
Why?
|
| Transcription, Genetic | 4 | 2009 | 3415 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 1993 | 131 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1991 | 211 | 0.030 |
Why?
|
| Mammals | 1 | 1994 | 374 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1993 | 121 | 0.030 |
Why?
|
| Phosphopeptides | 1 | 1993 | 73 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 676 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1993 | 356 | 0.030 |
Why?
|
| Lung | 2 | 1994 | 3268 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 1345 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1994 | 498 | 0.030 |
Why?
|
| Centrioles | 1 | 1992 | 16 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 1005 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1992 | 120 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1992 | 174 | 0.030 |
Why?
|
| Phosphotyrosine | 2 | 1989 | 125 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 1021 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 1994 | 588 | 0.030 |
Why?
|
| Piperazines | 1 | 2021 | 2153 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1989 | 161 | 0.030 |
Why?
|
| Lysosomes | 1 | 2014 | 347 | 0.020 |
Why?
|
| Tetrahymena | 1 | 1991 | 7 | 0.020 |
Why?
|
| Industry | 1 | 2011 | 50 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1992 | 269 | 0.020 |
Why?
|
| Tubulin | 1 | 1992 | 203 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1989 | 104 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2017 | 697 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2021 | 1920 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 1617 | 0.020 |
Why?
|
| Calcium | 5 | 1988 | 1597 | 0.020 |
Why?
|
| Caseins | 2 | 1988 | 79 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 4789 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2011 | 83 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 1603 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2007 | 6484 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2011 | 96 | 0.020 |
Why?
|
| Trypsin | 2 | 1988 | 160 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 1435 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 1991 | 164 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 1988 | 92 | 0.020 |
Why?
|
| Yeasts | 1 | 1990 | 77 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1997 | 908 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1993 | 452 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 1599 | 0.020 |
Why?
|
| ras-GRF1 | 1 | 1990 | 6 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 1993 | 487 | 0.020 |
Why?
|
| Time Factors | 5 | 2001 | 13103 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2019 | 1542 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2016 | 2958 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2010 | 62 | 0.020 |
Why?
|
| Rats, Inbred Strains | 3 | 1985 | 483 | 0.020 |
Why?
|
| ras Proteins | 1 | 2014 | 803 | 0.020 |
Why?
|
| Career Choice | 1 | 2011 | 206 | 0.020 |
Why?
|
| Intestinal Mucosa | 2 | 2009 | 1124 | 0.020 |
Why?
|
| United States | 2 | 2017 | 15962 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 2502 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 128 | 0.020 |
Why?
|
| Maturation-Promoting Factor | 1 | 1989 | 22 | 0.020 |
Why?
|
| Virus Replication | 2 | 2003 | 761 | 0.020 |
Why?
|
| Xenopus laevis | 2 | 2004 | 273 | 0.020 |
Why?
|
| Antibodies | 1 | 1992 | 835 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 1992 | 642 | 0.020 |
Why?
|
| Fluorides | 1 | 1988 | 28 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 1988 | 29 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2017 | 1462 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1988 | 44 | 0.020 |
Why?
|
| Centrifugation | 1 | 1988 | 65 | 0.020 |
Why?
|
| Metaphase | 1 | 1988 | 124 | 0.020 |
Why?
|
| Hydroxyapatites | 1 | 1988 | 11 | 0.020 |
Why?
|
| Durapatite | 1 | 1988 | 25 | 0.020 |
Why?
|
| Chromatography | 1 | 1988 | 60 | 0.020 |
Why?
|
| Meiosis | 1 | 1989 | 185 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 834 | 0.020 |
Why?
|
| Cytokines | 1 | 2017 | 2836 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1084 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1988 | 145 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1988 | 141 | 0.020 |
Why?
|
| Vertebrates | 1 | 1988 | 62 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 231 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 7220 | 0.020 |
Why?
|
| Cryptochromes | 1 | 2007 | 14 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2007 | 81 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 214 | 0.020 |
Why?
|
| Period Circadian Proteins | 1 | 2007 | 42 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2007 | 33 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 2561 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2007 | 52 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 1089 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 386 | 0.020 |
Why?
|
| Adenylyl Cyclase Inhibitors | 2 | 1986 | 12 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2336 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 260 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2006 | 127 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 1986 | 40 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1991 | 816 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 557 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 948 | 0.020 |
Why?
|
| Transglutaminases | 1 | 1986 | 100 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1988 | 594 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 4882 | 0.020 |
Why?
|
| Spermidine | 2 | 1986 | 9 | 0.020 |
Why?
|
| Acetylation | 1 | 2007 | 519 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 6185 | 0.020 |
Why?
|
| Ki-67 Antigen | 2 | 1998 | 685 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 540 | 0.020 |
Why?
|
| Colon | 1 | 2009 | 689 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1986 | 132 | 0.020 |
Why?
|
| Fluorescence Polarization | 1 | 1985 | 22 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 1985 | 1744 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1985 | 116 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 689 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2005 | 124 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2312 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1986 | 296 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2007 | 1070 | 0.010 |
Why?
|
| Physical Education and Training | 1 | 1984 | 20 | 0.010 |
Why?
|
| Aphidicolin | 2 | 1994 | 30 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 145 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 1259 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2005 | 229 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1984 | 129 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 594 | 0.010 |
Why?
|
| Acylation | 1 | 2003 | 23 | 0.010 |
Why?
|
| Aged | 6 | 2019 | 73188 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 462 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 3538 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 631 | 0.010 |
Why?
|
| Membrane Lipids | 1 | 1983 | 48 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 181 | 0.010 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2002 | 56 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1997 | 1119 | 0.010 |
Why?
|
| Ovum | 2 | 1993 | 37 | 0.010 |
Why?
|
| Bile Canaliculi | 1 | 1982 | 6 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 5436 | 0.010 |
Why?
|
| Muscles | 1 | 1984 | 462 | 0.010 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2002 | 32 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2003 | 196 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 282 | 0.010 |
Why?
|
| Middle Aged | 6 | 2019 | 90030 | 0.010 |
Why?
|
| Endotoxins | 1 | 1982 | 98 | 0.010 |
Why?
|
| Hamartoma | 1 | 1982 | 87 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2001 | 94 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 163 | 0.010 |
Why?
|
| Age Factors | 3 | 1997 | 5485 | 0.010 |
Why?
|
| Putrescine | 1 | 1981 | 18 | 0.010 |
Why?
|
| Spermine | 1 | 1981 | 25 | 0.010 |
Why?
|
| Alanine | 1 | 2001 | 251 | 0.010 |
Why?
|
| Mesenchymoma | 1 | 1980 | 14 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2001 | 219 | 0.010 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1980 | 74 | 0.010 |
Why?
|
| Cecal Neoplasms | 1 | 1980 | 4 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1147 | 0.010 |
Why?
|
| Lysine | 1 | 2002 | 428 | 0.010 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1982 | 331 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 340 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 2489 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 1980 | 141 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 3653 | 0.010 |
Why?
|
| Rabbits | 2 | 1995 | 1089 | 0.010 |
Why?
|
| Italy | 1 | 1980 | 186 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1981 | 581 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 739 | 0.010 |
Why?
|
| Oligodendroglioma | 1 | 1999 | 105 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 1984 | 400 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 4190 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 7245 | 0.010 |
Why?
|
| Estradiol | 1 | 2001 | 885 | 0.010 |
Why?
|
| Carcinoid Tumor | 1 | 1980 | 281 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2001 | 907 | 0.010 |
Why?
|
| Chaperonins | 1 | 1997 | 26 | 0.010 |
Why?
|
| Appendiceal Neoplasms | 1 | 1980 | 250 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1981 | 659 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12515 | 0.010 |
Why?
|
| Phosphorylase Kinase | 2 | 1986 | 9 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1999 | 334 | 0.010 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1980 | 441 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1998 | 1214 | 0.010 |
Why?
|
| Succinates | 1 | 1995 | 28 | 0.010 |
Why?
|
| Leupeptins | 1 | 1995 | 73 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2001 | 876 | 0.010 |
Why?
|
| Bisbenzimidazole | 1 | 1994 | 8 | 0.010 |
Why?
|
| Guanylyl Imidodiphosphate | 2 | 1986 | 7 | 0.010 |
Why?
|
| Electroporation | 1 | 1995 | 127 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1994 | 91 | 0.010 |
Why?
|
| Sex Factors | 1 | 1980 | 2189 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1980 | 1068 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 5992 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 213 | 0.010 |
Why?
|
| Crystallography | 1 | 1993 | 57 | 0.010 |
Why?
|
| Sarcoma Viruses, Murine | 1 | 1993 | 11 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 1993 | 11 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1993 | 43 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1993 | 130 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1993 | 37 | 0.010 |
Why?
|
| DNA Probes | 1 | 1993 | 248 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1993 | 278 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1993 | 166 | 0.010 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 1992 | 64 | 0.010 |
Why?
|
| Casein Kinases | 1 | 1992 | 7 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1993 | 191 | 0.010 |
Why?
|
| Prophase | 1 | 1992 | 8 | 0.010 |
Why?
|
| Liver | 1 | 1982 | 3123 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 1998 | 13977 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1980 | 1437 | 0.010 |
Why?
|
| Drosophila | 1 | 1997 | 911 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1994 | 350 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 736 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 1980 | 1238 | 0.010 |
Why?
|
| Mink | 1 | 1991 | 9 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 335 | 0.010 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 1991 | 13 | 0.010 |
Why?
|
| Threonine | 1 | 1991 | 165 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1991 | 238 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 294 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1992 | 289 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 1997 | 1645 | 0.010 |
Why?
|
| Urea | 1 | 1992 | 306 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 1991 | 184 | 0.010 |
Why?
|
| Vanadates | 1 | 1989 | 22 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1989 | 28 | 0.010 |
Why?
|
| Nitrogen | 1 | 1990 | 181 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1997 | 2264 | 0.010 |
Why?
|
| Estrogens | 1 | 1993 | 845 | 0.010 |
Why?
|
| Epithelium | 1 | 1991 | 805 | 0.000 |
Why?
|
| Carcinoma | 1 | 1980 | 2627 | 0.000 |
Why?
|
| Cell Membrane | 2 | 1982 | 906 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1997 | 4967 | 0.000 |
Why?
|
| Calcineurin | 1 | 1988 | 131 | 0.000 |
Why?
|
| Phosphatidyl-N-Methylethanolamine N-Methyltransferase | 1 | 1986 | 1 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1986 | 42 | 0.000 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 1 | 1986 | 12 | 0.000 |
Why?
|
| Columbidae | 1 | 1986 | 24 | 0.000 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1986 | 74 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1986 | 125 | 0.000 |
Why?
|
| Bucladesine | 1 | 1986 | 32 | 0.000 |
Why?
|
| Phenothiazines | 1 | 1986 | 10 | 0.000 |
Why?
|
| Phosphofructokinase-1 | 1 | 1986 | 13 | 0.000 |
Why?
|
| Aminophylline | 1 | 1986 | 11 | 0.000 |
Why?
|
| Temperature | 1 | 1987 | 542 | 0.000 |
Why?
|
| Myosins | 1 | 1986 | 97 | 0.000 |
Why?
|
| Porins | 1 | 1986 | 57 | 0.000 |
Why?
|
| Chickens | 1 | 1986 | 791 | 0.000 |
Why?
|
| Magnesium | 1 | 1986 | 173 | 0.000 |
Why?
|
| Methyltransferases | 1 | 1986 | 153 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 1998 | 39679 | 0.000 |
Why?
|
| Swine | 1 | 1989 | 1611 | 0.000 |
Why?
|
| Ion Channels | 1 | 1986 | 241 | 0.000 |
Why?
|
| Lymphoma | 1 | 1993 | 1514 | 0.000 |
Why?
|
| Capillaries | 1 | 1984 | 103 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1986 | 661 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1986 | 428 | 0.000 |
Why?
|
| Amino Acids | 1 | 1986 | 787 | 0.000 |
Why?
|
| Cell Count | 1 | 1984 | 524 | 0.000 |
Why?
|
| Isoproterenol | 1 | 1983 | 135 | 0.000 |
Why?
|
| Sodium Fluoride | 1 | 1982 | 34 | 0.000 |
Why?
|
| Alleles | 1 | 1987 | 2507 | 0.000 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1981 | 111 | 0.000 |
Why?
|
| Lipopolysaccharides | 1 | 1982 | 593 | 0.000 |
Why?
|
| Adult | 1 | 1982 | 81540 | 0.000 |
Why?
|